Skip to main
AMTX

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Aemetis is a renewable fuel and biochemicals company with a positive outlook due to its strong Q2 revenue growth, progress on all businesses, large product potential for renewable fuels, and upcoming catalysts such as monetization of fuel and tax credits. Although the company's operations and financials may appear challenged, it is close to an inflection point and has a favorable outlook for 2026. Additionally, Aemetis has a very strong financial plan and positive regulatory paths, which make it an attractive stock with high potential for rewards.

Bears say

Aemetis is a promising renewable fuel and biochemicals company with a positive outlook for regulatory approvals and significant upside potential from federal Section 45Z production tax credits, improved ethanol economics, and progress on various projects. However, there are risks inherent to the company's high-risk business model and lack of recent updates on its strong 5-year financial plan. Key upcoming catalysts such as further monetization of fuel and tax credits, improved ethanol economics, and progress on new projects may drive the stock, but there are also risks such as political and regulatory uncertainties and changes in market and consumer demand.

Aemetis (AMTX) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Aemetis (AMTX) has a Strong Buy consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.